Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2003-05-14
2008-12-09
Ewoldt, G. R. (Department: 1644)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C530S300000
Reexamination Certificate
active
07462486
ABSTRACT:
A method is disclosed to identify a T cell receptor (TCR) variable (V) peptide of use as a therapeutic agent in a subject. A method is also disclosed for monitoring the efficacy of a T Cell Receptor (TCR) V peptide for the treatment of a subject. In another embodiment, a method is disclosed for selecting a TCR V peptide of use in therapy for a subject having an autoimmune disease.
REFERENCES:
patent: 5194425 (1993-03-01), Sharma et al.
patent: 5223426 (1993-06-01), Skibbens et al.
patent: 5569585 (1996-10-01), Goodwin et al.
patent: 5612035 (1997-03-01), Howell et al.
patent: 5614192 (1997-03-01), Vandenbark
patent: 5776459 (1998-07-01), Vandenbark
patent: 5837246 (1998-11-01), Howell et al.
patent: 5856446 (1999-01-01), Weiner et al.
patent: 5858968 (1999-01-01), Weiner et al.
patent: 5869093 (1999-02-01), Weiner et al.
patent: 5939281 (1999-08-01), Lehmann et al.
patent: 5939400 (1999-08-01), Steinman et al.
patent: 6019971 (2000-02-01), Weiner et al.
patent: 6039947 (2000-03-01), Weiner et al.
patent: 6045796 (2000-04-01), Sriram et al.
patent: 6090387 (2000-07-01), Howell et al.
patent: 6113903 (2000-09-01), Albertini et al.
patent: 6159470 (2000-12-01), Howell et al.
patent: 6197926 (2001-03-01), Gaur et al.
patent: 6207645 (2001-03-01), Howell et al.
patent: 6218132 (2001-04-01), Spack et al.
patent: 6221352 (2001-04-01), Howell et al.
patent: 6958327 (2005-10-01), Hillisch et al.
patent: 2002/0183299 (2002-12-01), Voskuhl
patent: 0 159 739 (1985-10-01), None
patent: 0957359 (1999-11-01), None
patent: 10175854 (1998-06-01), None
patent: WO 94/25063 (1994-11-01), None
patent: WO 99/58977 (1999-11-01), None
Vandenbark et al., 2005, Current Drug Targets, vol. 4: 217-229.
Thornton et al., 1998, J. Exp. Med. vol. 188: 287-296.
Venken et al., 2006, J. Neur. Res. vol. 83: 1432-1446.
Vandenbark et al., 2000, Crit. Rev. Immunology, vol. 20: 57-83.
Vandenbark et al., 2001, J. Neur. Res. vol. 66: 171-176.
Janeway and Travers, 1997, Immunobiology, pp. 7:26-7:27.
Arden et al., “Human T-cell receptor variable gene segment families,”Immunogenetics42:455-500, 1995.
Brosterhaus et al., “Enrichment and detection of live antigen-specific CD4+ T cells based on cytokine secretion,”Eur. J. Immunol. 29:4053-4059, 1999.
Choi et al., “Interaction ofStaphylococcus aureustoxin ‘superantigens’ with human T cells,”Proc. Natl. Acad. Sci. USA86:8941-8945, 1989.
Chou et al., “Immunity to TCR peptides in multiple sclerosis,”J. Immunol. 152:2520-2529, 1994.
Chou et al., “MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR Vβ CDR2 peptides: comparison with myelin basic protein-specific T cells,”J. Neuroscience Res. 45:838-851, 1996.
Cochlovirus et al., “In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the Tepitope program,”J. Immunol. 165:4731-4741, 2000.
Concannon et al., “Diversity and structure of human T-cell receptor β-chain variable region genes,”Proc. Natl. Acad. Sci. USA83:6598-6602, 1986.
Czerkinsky et al., “Reverse ELISPOT assay for clonal analysis of cytokine production,”J. Immunol. Methods110:29-36, 1998.
Evavold et al., “Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands,”Immunology Today14:602-609, 1993.
Fairchild, “Altered peptide ligands: prospects for immune intervention in autoimmune disease,”Eur. J. Immunogenet. 24:155-167, 1997.
Genevee et al., “An experimentally validated panel of subfamily-specific oligonucleotide primer (Vα-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction,”Eur. J. Immunol. 22:1261-1269, 1992.
Kay et al., “Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a study of the eastern cooperative oncology group (E9487),”Leuk. Lymphoma33:127-133, 1999.
Kimura et al., “Sequences and repertoire of the human T cell receptor α and β chain variable region genes in thymocytes,”Eur. J. Immunol. 17:375-383, 1987.
Mancia et al., “Characterization of the T-cell receptor V-β repertoire in Kawasaki disease,”Scand. J. Immunol. 48:443-449, 1998.
Olsson et al., “Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ,”J. Clin. Invest. 86:981-985, 1990.
Robinson, “The human T cell receptor β-chain gene complex contains at least 57 variable gene segments,”J. Immunol. 146:4392-4397, 1991.
Savoie et al., “Use of Bonsai decision trees for the identification of potential MHC class I peptide epitope motifs,”Pac. Symp. Biocomput. 1999:182-189, 1999.
Vandenbark et al., “Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trail,”Nature Med. 2:1109-1115, 1996.
Acha-Orbea et al., “Limited Heterogeneity of T Cell Receptors from Lymphocytes Mediating Autoimmune Encephalomyelitis Allows Specific Immune Intervention,”Cell54:263-273, Jul. 15, 1988.
Gilmore et al., “Effect of Estradiol on Cytokine Secretion by Proteolipid Protein-Specific T Cell Clones Isolated from Multiple Sclerosis Patients and Normal Control Subjects,”J. Immunol. 158:446-451, (1997).
Ewoldt G. R.
Juedes Amy
Klarquist & Sparkman, LLP
Oregon Health & Science University
The United States of America as represented by the Department of
LandOfFree
Methods of selecting T cell receptor V peptides for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of selecting T cell receptor V peptides for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of selecting T cell receptor V peptides for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4034848